The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease

Author(s): Voineskos AN, Lerch JP, Felsky D, Shaikh S, Rajji TK, et al.

Abstract

Context  The brain-derived neurotrophic factor (BDNF) Val66Met (rs6265) polymorphism may predict the risk of Alzheimer disease (AD). However, genetic association studies of the BDNF gene with AD have produced equivocal results. Imaging-genetics strategies may clarify the manner in which BDNF gene variation predicts the risk of AD via characterization of its effects on at-risk structures or neural networks susceptible in this disorder.

Objective  To determine whether the BDNF Val66Met gene variant interacts with age to predict brain and cognitive measures in healthy volunteers across the adult lifespan in an intermediate phenotype pattern related to AD by examining (1) cortical thickness, (2) fractional anisotropy of white matter tracts (ie, white matter integrity), and (3) episodic memory performance.

Design  A cross-sectional study using genetics, high-resolution magnetic resonance imaging, diffusion tensor imaging, and cognitive testing in healthy individuals spanning the adult lifespan.

Similar Articles

The non-cognitive features of dementia

Author(s): Allen NHP, Burns A

Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Author(s): Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Engchild J, et al.

Protein folding assisted by chaperones

Author(s): Borges JC, Ramos CH

Heat shock protein 70 in Alzheimer's disease

Author(s): Lu RC, Tan MS, Wang H, Xie AM, Yu JT, et al.

BDNF is essential to promote persistence of long-term memory storage

Author(s): Bekinstein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, et al.

BDNF in sleep, insomnia, and sleep deprivation

Author(s): Schmitt K, Holsboer-Trachler E, EC-Kert A

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease

Author(s): Philips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, et al.

The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients

Author(s): Ciaramella A, Salani F, Bizzoni F, Orfei MD, Langella Rangelucci F, et al.

Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?

Author(s): Fahnestock M, Garzon D, Holsinger RM, Michalski B

BDNF and full-length and truncated TrkB expression in Alzheimer disease

Author(s): Ferreer I, Marin C, Rey MJ, Ribalta T, Goutane, et al.

Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease

Author(s): Nacmias B, Tedde A, Forleo P, Piacentini S, Guamieri BM, et al.